BlogMajority of Canadians living with advanced stage Parkinson’s Disease will now have publicly funded access to NEUPRO®. Majority of Canadians living with advanced stage Parkinson’s Disease will now have publicly funded access to NEUPRO®. Posted Date : Jun 14, 2018 BREAKING NEWS! UCB Canada just announced that the majority of Canadians living with advanced stage Parkinson’s Disease will now have publicly funded access to NEUPRO®. The drug helps to alleviate debilitating symptoms including tremors, slow movement and stiffness. “It’s encouraging for patients living with Parkinson’s and their caregivers to know that they have treatment options at every stage of this life-changing disease,” says Joyce Gordon, Chief Executive Officer, Parkinson Canada. “As a condition that manifests itself differently from person to person, and gets worse over time, symptom control is critical.” To learn more about the funding of NEUPRO® for Canadians battling APD, read UCB Canada Inc.’s news release. Share this post: Your Story Matters: Inspire and Connect Inspire hope and connect with others by sharing your Parkinson’s journey. Your voice can make a difference. Share your story Discover more like this Apr 2, 2024 Living well with Parkinson’s is possible - Parkinson Canada marks Parkinson’s Awareness Month in April Mar 27, 2024 Canadian Open Parkinson Network opens new Halifax site Mar 4, 2024 VYALEV (foslevodopa/foscarbidopa solution) is now available in Canada